18F-FDG PET-CT在食管癌精确放疗中的应用

doi:10.3760/cma.j.issn.1673-422X.2015.12.012

摘要/Abstract

摘要： 放疗前对靶区进行精确勾画、修正靶区和调节治疗计划，放疗后评价疗效对食管癌的治疗至关重要。18F氟脱氧葡萄糖(18FFDG)正电子发射计算机断层显像（PET）CT将PET功能影像和CT解剖影像有机结合，为PET提供更多的解剖细节，并且可从分子水平反映肿瘤组织和正常组织的生化变化和代谢状态之间的差异，为食管癌的治疗提供更多有价值的帮助。

关键词: 食管肿瘤, 放射疗法, 正电子发射断层显像术, 氟脱氧葡萄糖F18

Abstract: Precise target delineation, target amendment and treatment plan regulation before radiotherapy and effect evaluation after radiotherapy are critical for the treatment of esophageal cancer. 18Ffluorodeoxyglucose (FDG) positron emission tomography (PET)/CT, a unique combination of the functionally metabolic PET imaging and the anatomical CT imaging, can provide more anatomical details for PET, and it can reflect differences in tumor and normal tissue metabolic states and biochemical changes at the molecular level, and provide more valuable assistance for the treatment of esophageal cancer.

Key words: Esophageal neoplasms, Radiotherapy, Positron-emission tomography, Fluorodeoxyglucose F18

魏丽,李多杰. 18F-FDG PET-CT在食管癌精确放疗中的应用[J]. 国际肿瘤学杂志, 2015, 42(12): 928-931.

Wei Li, Li Duojie. Applications of 18FFDG PETCT for accurate radiotherapy of esophageal cancer[J]. Journal of International Oncology, 2015, 42(12): 928-931.

参考文献

［1］ Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a metaanalysis［J］. Lancet Oncol, 2007, 8(3): 226-234. ［2］ Tan S, Kligerman S, Chen W, et al. Spatialtemporal ［18F］ FDGPET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy［J］. Int J Radiat Oncol Biol Phys, 2013, 85(5): 1375-1382. ［3］ Macmanus M, Nestle U, Rosenzweig KE, et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 20062007［J］. Radiother Oncol, 2009, 91(1): 85-94. ［4］ Muijs CT, Beukema JC, Pruim J, et al. A systematic review on the role of FDGPET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer［J］. Radiother Oncol, 2010, 97(2): 165-171. ［5］李军凯, 左效艳, 许文, 等. PET/CT对于食管癌放射治疗的研究进展［J］. 中国医药导刊, 2012, 14(8): 1311-1313. ［6］李娟, 祝淑钗, 刘志坤, 等. (18)FFDG PET和CT对食管癌临床分期的价值［J］. 中国肿瘤临床, 2011, 38(23): 1449-1452. ［7］李娟, 祝淑钗, 刘志坤, 等. 超声内镜结合CT扫描在食管癌临床分期中的应用［J］. 中国肿瘤临床, 2011, 38(1): 46-49. ［8］ Seol KH, Lee JE. PET/CT planning during chemoradiotherapy for esophageal cancer［J］. Radiat Oncol J, 2014, 32(1): 31-42. ［9］ Jeganathan R, Mcguigan J, Campbell F, et al. Does preoperative estimation of oesophageal tumour metabolic length using 18Ffluorodeoxyglucose PET/CT images compare with surgical pathology length?［J］. Eur J Nucl Med Mol Imaging, 2011, 38(4): 656-662. ［10］ Wang F, Shen LY, Ma SH, et al. Advantages of positron emission tomographycomputed tomography imaging in esophageal squamous cell carcinoma［J］. Dis Esophagus, 2013, 26(8): 832-837. ［11］ Karashima R, Watanabe M, Imamura Y, et al. Advantages of FDGPET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer［J］. Surg Today, 2015, 45(4): 471-477. ［12］ Tan R, Yao SZ, Huang ZQ, et al. Combination of FDG PET/CT and contrastenhanced MSCT in detecting lymph node metastasis of esophageal cancer［J］. Asian Pac J Cancer Prev, 2014, 15(18): 7719-7724. ［13］ Kato H, Kimura H, Nakajima M, et al. The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer［J］. Oncol Rep, 2008, 20(4): 857-862. ［14］ Liu CJ, Cheng JC, Lee JM, et al. Patterns of nodal metastases on 18FFDG PET/CT in patients with esophageal squamous cell carcinoma are useful to guide treatment planning of radiotherapy［J］. Clin Nucl Med, 2015, 40(5): 384-389. ［15］谢彦婷, 郑荣, 吴宁, 等. 食管癌IMRT前FDG PETCT显像对治疗决策的影响［J］. 中华放射肿瘤杂志, 2014, 23(1): 31-34. ［16］ Schreurs LM, Busz DM, Paardekooper GM, et al. Impact of 18fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal interobserver variability: PET/CT improves esophageal target definition［J］. Dis Esophagus, 2010, 23(6): 493-501. ［17］ Nkhali L, Thureau S, EdetSanson A, et al. FDGPET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses［J］. Acta Oncol, 2015, 54(6): 909-915. ［18］ Yu W, Cai XW, Liu Q, et al. Safety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by (18)FDGPET/CT for esophageal cancer［J］. Radiother Oncol, 2015, 114(2): 195-200. ［19］ Huang JW, Yeh HL, Hsu CP, et al. To evaluate the treatment response of locally advanced esophageal cancer after preoperative chemoradiotherapy by FDGPET/CT scan［J］. J Chin Med Assoc, 2015, 78(4): 229-234. ［20］ Park JS, Choi JY, Moon SH, et al. Response evaluation after neoadjuvant chemoradiation by positron emission tomographycomputed tomography for esophageal squamous cell carcinoma［J］. Cancer Res Treat, 2013, 45(1): 22-30.

[1]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[2]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[3]	刘静, 刘芹, 黄梅. 基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[4]	万芳, 杨钢, 李睿, 万启晶. 食管癌患者血清miR-497、miR-383水平及临床意义[J]. 国际肿瘤学杂志, 2024, 51(4): 204-209.
[5]	李书月, 马辰莺, 周菊英, 徐晓婷, 秦颂兵. 寡转移非小细胞肺癌的放疗进展[J]. 国际肿瘤学杂志, 2024, 51(3): 170-174.
[6]	李济时, 陆钊群, 刘俊茹, 吕建勋, 陈霜, 沈琳, 徐志渊, 吴平安. 新辅助放疗联合部分喉切除术治疗喉滑膜肉瘤1例并文献复习[J]. 国际肿瘤学杂志, 2024, 51(2): 123-125.
[7]	中国医师协会放射肿瘤治疗医师分会, 中华医学会放射肿瘤治疗学分会, 中国抗癌协会肿瘤放射治疗专业委员会. 中国食管癌放射治疗指南（2023年版）[J]. 国际肿瘤学杂志, 2024, 51(1): 1-20.
[8]	高新雨, 李振江, 孙洪福, 韩丹, 赵倩, 刘成新, 黄伟. 基于MR加速器的MR引导放疗在食管癌患者中的临床应用[J]. 国际肿瘤学杂志, 2024, 51(1): 37-42.
[9]	崔腾璐, 吕璐, 孙鹏飞. 放疗联合免疫治疗在头颈部鳞状细胞癌治疗中的应用[J]. 国际肿瘤学杂志, 2023, 50(9): 548-552.
[10]	山东省医学会肺癌食管癌多学科联合委员会. 山东省医学会食管癌多学科规范化诊疗指南（2023年版）[J]. 国际肿瘤学杂志, 2023, 50(7): 385-397.
[11]	李青珊, 谢鑫, 张楠, 刘帅. 放疗联合系统治疗在乳腺癌中的应用进展[J]. 国际肿瘤学杂志, 2023, 50(6): 362-367.
[12]	许萌, 姜伟, 朱海涛, 曹雄锋. 癌相关成纤维细胞在肿瘤放疗抵抗中的研究进展[J]. 国际肿瘤学杂志, 2023, 50(4): 227-230.
[13]	石小琪, 汪红艳. 肠道菌群与放射性肠炎的相互作用及研究进展[J]. 国际肿瘤学杂志, 2023, 50(4): 244-247.
[14]	冀世玉, 张明鑫, 谢华红, 白渊, 王彤. 不同支架治疗晚期食管癌患者的疗效观察[J]. 国际肿瘤学杂志, 2023, 50(2): 76-81.
[15]	巩合义, 伊艳, 张健, 李宝生. 局部晚期可手术食管癌经新辅助放化疗达临床完全缓解后的处理策略[J]. 国际肿瘤学杂志, 2023, 50(12): 745-750.